Study 1 of 3 for search of: "Croup"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparing Different Ways of Delivering Humidity to Children With Croup
This study has been completed.
Sponsors and Collaborators: The Hospital for Sick Children
Physicians Services Incorporated (PSI)
Information provided by: The Hospital for Sick Children
ClinicalTrials.gov Identifier: NCT00230841
  Purpose

Croup affects 5% of children under 6 years of age, resulting in visits to hospital Emergency Departments, and in 1% of children, hospitalization. Traditionally, the first therapy offered is humidification which can liquify airway secretions and decrease airway swelling. This study will compare the effectivenesss of 40% and 100% humidity through a specially designed machine called a nebulizer, with the usual humidity set-up (blown into the patient’s face from a hose).


Condition Intervention Phase
Croup
Device: nebulized humidity
Phase II

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Dose Comparison, Parallel Assignment, Efficacy Study
Official Title: Efficacy of Optimal Versus 'Traditional' Delivery of Humidity in Children With Croup

Further study details as provided by The Hospital for Sick Children:

Primary Outcome Measures:
  • changes in the croup score from baseline to 30 and 60 minutes

Secondary Outcome Measures:
  • steroid or epinephrine treatment at 60 minutes
  • discharge rate at 60 minutes
  • change in pulse, respiratory rate, and oxygen saturation at 60 minutes

Estimated Enrollment: 129
Study Start Date: September 2001
Estimated Study Completion Date: April 2004
  Eligibility

Ages Eligible for Study:   3 Months to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • children aged 3 months - 10 years
  • croup score greater than or equal to 2 after a 30 minute waiting period

Exclusion Criteria:

  • Symptoms of croup requiring immediate intervention with nebulized epinephrine or intubation
  • symptoms or signs of alternative causes of stridor
  • inability of caregivers to understand or speak English and/or sign for informed consent
  • history of chronic pulmonary disease except for asthma, or co-existent systemic disease
  • previous history of intubation
  • duration of present illness >1 week
  • systemic or inhaled glucocorticoids in previous 48 hours
  • epinephrine in previous 4 hours
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230841

Locations
Canada, Ontario
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8
Sponsors and Collaborators
The Hospital for Sick Children
Physicians Services Incorporated (PSI)
Investigators
Principal Investigator: Dennis Scolnik, MD The Hospital for Sick Children, Toronto Canada
  More Information

Publications of Results:
Study ID Numbers: 0020010158
Study First Received: September 29, 2005
Last Updated: October 10, 2006
ClinicalTrials.gov Identifier: NCT00230841  
Health Authority: Canada: Ethics Review Committee

Keywords provided by The Hospital for Sick Children:
croup
humidity therapy
pediatrics

Study placed in the following topic categories:
Croup
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Laryngitis
Laryngeal Diseases

ClinicalTrials.gov processed this record on January 16, 2009